ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fracture"

  • Abstract Number: 2005 • ACR Convergence 2023

    Secondary Prevention of Osteoporosis in Hip Fracture Care for Elderly Patients. Clinical and Functional Profile of Users

    Belén Miguel Ibáñez, Alfonso González Ramírez, Olga Martínez González, Ana Isabel Turrión Nieves, Marta Ibáñez Martínez, Carolina Cristina Chacón Vélez, Laura Blanco Ramis, Manuel Cipriano Martín Martínez, Cristina Hidalgo Calleja, Carlos Alberto Montilla Morales, Susana Gómez Castro, Juan Francisco Blanco Blanco and Carmen Pablos Hernández, University Healthcare Complex of Salamanca, Salamanca, Spain

    Background/Purpose: Osteoporosis is a first-rate problem in an increasingly ageing population. Falls among the elderly are a severe geriatric syndrome with relevant secondary effects. Fractures…
  • Abstract Number: 2010 • ACR Convergence 2023

    B-FROST: Chronic OBstructive Pulmonary Disease and Vertebral FRacture of OSTeoporotic Origin: Results of a Real-life Cohort

    Amine Mouamnia, Armentieres Hospital Center, Armentieres, France

    Background/Purpose: Chronic obstructive pulmonary disease (COPD) is a chronic disease of the airways. It is mainly caused by smoking. Active smoking is a risk factor…
  • Abstract Number: 2011 • ACR Convergence 2023

    Predicting Fractures in Patients with Isolated Lumbar Spine Osteoporosis Compared to Those with Isolated Hip Osteoporosis

    Nicholas Rossi1, Aamir Saeed2, Aqib Khan3, Hamzah Amin2, Ummaz Nadeem2, Zain Sultan3 and Marwan Bukhari2, 1University Hospitals of Morecambe Bay Foundation Trust, Worksop, United Kingdom, 2Lancaster University, Lancaster, United Kingdom, 3University Hospitals of Morecambe Bay Foundation Trust, Lancaster, United Kingdom

    Background/Purpose: Osteoporosis (OP) presents with fragility fractures, which can cause significant disability and cost to health services globally. There has been extensive research looking at…
  • Abstract Number: 2013 • ACR Convergence 2023

    Clinical Characteristics and Risk Factors Associated with Fragility Fractures in Patients with Primary and Idiopathic Mast Cell Activation Syndromes

    Ana Isabel Ramos Lisbona1, Karen Carpio Astudillo1, Filip Skrabski1, Alicia Prieto García1, Isabel Castrejon1, Javier Rivera2, José María Álvaro-Gracia1 and Teresa González1, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Background/Purpose: Mast Cell Activation Syndromes (MCAS) are a group of disorders presenting with episodic multisystem symptoms, predominantly anaphylaxis, as the result of mast cell mediator…
  • Abstract Number: 2123 • ACR Convergence 2023

    Dose Trabecular Bone Score (TBS) Add Predictive Value to Fracture Risk Assessment (FRAX) in Rheumatoid Arthritis?

    Jia-Feng Chen1, Tien-Tsai Cheng2 and Hong-Yo Kang3, 1Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung, Taiwan, 3Graduate Institute of Clinical Medical Sciences, Chang Gung University, College of Medicine, Kaohsiung, Taiwan

    Background/Purpose: Trabecular bone score (TBS) of lumbar spine is a dual X-ray densitometry (DXA)-based tool to evaluate bone microarchitecture, providing information on bone quality in…
  • Abstract Number: 2138 • ACR Convergence 2023

    Frailty Is a Predictor of Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis

    K Wysham1, Hannah Brubeck2, Aaron Baraff3, Punyasha Roul4, Namrata Singh5, James Andrews6, Grant Cannon7, Gary Kunkel8, Ted R Mikuls9, Bryant England4, Dolores Shoback10, Patti Katz11, Jose Garcia12, Ariela Orkaby13 and Joshua Baker14, 1VA Puget Sound/University of Washington, Seattle, WA, 2VA Puget Sound Health Care System, Seattle, WA, 3VA Puget Sound Seattle, Seattle, WA, 4University of Nebraska Medical Center, Omaha, NE, 5University of Washington, Bellevue, WA, 6University of Washington, Seattle, WA, 7University of Utah and Salt Lake City VA, Salt Lake City, UT, 8University of Utah, Salt Lake City, UT, 9Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, 10San Francisco VA Medical Center, San Francisco, CA, 11University of California San Francisco, San Rafael, CA, 12VA Puget Sound Healthcare System, Seattle, WA, 13Veterans Affairs Boston Healthcare System & Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; VA Geriatric Research Education and Clinical Center, Boston, MA, 14University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Frailty occurs prematurely in RA. Levels of frailty are higher in Veteran populations than civilians1. Frailty has been shown to predict osteoporotic fractures in…
  • Abstract Number: 2429 • ACR Convergence 2023

    Romosozumab versus Denosumab in High-risk Patients Treated with Glucocorticoids: Interim 12-month Results from a Pilot Randomized Controlled Trial

    Chi Chiu Mok1, SAU MEI TSE2, Kar Li Kelly Chan3 and Wai Han Ma1, 1Tuen Mun Hospital, Hong Kong, Hong Kong, 2Tuen Mun Hospital, Hong Kong, China, 3Tuen Mun Hospital, Shatin, China

    Background/Purpose: To compare the efficacy and safety of romozosumab (ROMO) and denosumab (DEN) in high-risk patients treated with glucocorticoids (GCs). Methods: Adult patients (≥18 years)…
  • Abstract Number: L01 • ACR Convergence 2022

    Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study

    Giovanni Adami, Angelo Fassio, Davide Bertelle, Camilla Benini, Davide Gatti and Maurizio Rossini, Rheumatology Unit, University of Verona, Verona, Italy

    Background/Purpose: The recently published GLORIA (Glucocorticoid LOw-dose in RheumatoId Arthritis) trial has opened the debate around the benefits of glucocorticoids (GCs) in older patients with…
  • Abstract Number: 0574 • ACR Convergence 2022

    Osteoporosis in Elderly Men; An Underestimated and Underdiagnosed Morbid Entity

    Arash Mollaeian1 and Stanley Ballou2, 1Metro Health Medical Center/Case Western Reserve University, Rocky River, OH, 2Case Western Reserve University - Metro Health, Cleveland, OH

    Background/Purpose: 20-25% of osteoporosis-related fractures occur in men and the mortality of osteoporotic fractures is higher in men [1]. Nevertheless, no uniform consensus exists for…
  • Abstract Number: 1431 • ACR Convergence 2022

    Impact of Tofacitinib on Fracture Risk in Rheumatoid Arthritis

    Karen E Hansen1, Mahta Mortezavi2, Edward Nagy3, Cunshan Wang4, Carol A Connell4, Zaher Radi5, Heather J Litman6, Giovanni Adami7 and Maurizio Rossini7, 1Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Pfizer Inc, New York, NY, 3Pfizer Ltd, Tadworth, United Kingdom, 4Pfizer Inc, Groton, CT, 5Pfizer Inc., Cambridge, MA, 6CorEvitas, LLC, Waltham, MA, 7Rheumatology Unit, Department of Medicine, University of Verona, Verona, Italy

    Background/Purpose: Preclinical data suggest that tofacitinib stimulates osteoblast function and would have a protective effect on bone health and fracture risk in RA.1 We report…
  • Abstract Number: 0576 • ACR Convergence 2022

    Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (U.S.)

    Min Kim1, Leah J McGrath2, David Pritchard2, Peter Samai2, Jay Lin1, Robert Kees Stad3, Leslie Spangler1, Michele McDermott1, Brian D Bradbury4 and M Alan Brookhart2, 1Amgen, Inc., Thousand Oaks, CA, 2NoviSci, Inc., Durham, NC, 3Amgen Inc., Zug, Switzerland, 4Amgen Inc., 1 Amgen Center Drive

    Background/Purpose: Although clinical trials evaluating the efficacy of osteoporosis (OP) therapies have shown that denosumab (Dmab) significantly increases bone mineral density at pivotal sites compared…
  • Abstract Number: 1477 • ACR Convergence 2022

    Prevalence and Risk Factors of Fragility Fractures in Systemic Lupus Erythematosus: A Longitudinal Study over 12 Years

    Chi Chiu Mok1, Kar Li Chan2, Ling Yin Ho3 and Chi Hung To4, 1Tuen Mun Hospital, Hong Kong, China, 2Tuen Mun Hospital, Tsing Yi, Hong Kong, China, 3Tuen Mun Hospital, Hong Kong SAR, China, 4Hospital Authority, Hong Kong, Hong Kong

    Background/Purpose: To study the prevalence and risk factors of fragility fractures in a longitudinal cohort of patients with SLE.Methods: All patients who fulfilled ≥4 1997…
  • Abstract Number: 0577 • ACR Convergence 2022

    Bone Mineral Density of Radius 1/3 Led to a Better Fracture Prediction When Combined with Spine but Not Hip BMD: Results from the São Paulo Ageing & Health (SPAH) Study

    Diogo Domiciano1, Luana Machado2, Valeria Caparbo3, Carolina Teixeira Cidon4, Thais Helena Bonini Gorayeb4, Maria Aurora Gomes da SIlva5, ricardo Manoel de oliveira6, camille figueiredo3 and Rosa Pereira3, 1Hospital das Clinicas, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 5Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, 6RDO Diagnósticos Médicos, São Paulo, Brazil

    Background/Purpose: Bone mineral density (BMD) of the spine or hip are predictors of osteoporotic fracture, but individuals who sustain "osteoporosis-related" fractures frequently have normal BMD…
  • Abstract Number: 0727 • ACR Convergence 2022

    Primary Prevention of Fractures in Osteoporotic Patients in a Southern California Academic Health System

    Eugene Looi1, Gergana Mishkova1 and Christina Downey2, 1Loma Linda University, Loma Linda, CA, 2Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Osteoporosis (OSP) is common, carries high morbidity, significant cost and remains underrecognized and undertreated by health care providers (1). At a university-based academic health…
  • Abstract Number: 0889 • ACR Convergence 2022

    Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis

    Joshua Baker1, Katherine Wysham2, Bryant England3, Punyasha Roul4, Aleksander Lenert5, Grant Cannon6, Brian Sauer7, Geoffrey Thiele3 and Ted Mikuls8, 1University of Pennsylvania, Philadelphia, PA, 2VA Puget Sound/University of Washington, Seattle, WA, 3University of Nebraska Medical Center, Omaha, NE, 4UNMC, Omaha, NE, 5University of Iowa, Iowa City, IA, 6Retired, Salt Lake City, UT, 7Salt Lake City VA/University of Utah, Salt Lake City, UT, 8Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Adipokines are fat and muscle-secreted protein hormones that regulate metabolism. Adiponectin has been associated with fracture in the general population while the role of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology